Acuitas Therapeutics
Founded in 2009, this LNP delivery technology company advances nucleic acid drug delivery R&D and commercialization primarily through partners. Licensed platforms are not classified as company-owned drug candidates.
Corporate information
- Company entity
- Acuitas Therapeutics
- Headquarters / principal office
- Vancouver, British Columbia, CanadaOffice location disclosed on the corporate website; a sole legal or global headquarters is not inferred. ↗
- Founded
- 2009 ↗
- Ownership / capital status
- PrivatePrivately held (specific round not verified) ↗
- Official corporate reference
- https://acuitastx.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
Founded in 2009, this LNP delivery technology company advances nucleic acid drug delivery R&D and commercialization primarily through partners. Licensed platforms are not classified as company-owned drug candidates.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.